Mechanistically, SENP2 overexpression results in inhibition of the AKT/GSK3β/CTNNB1 pathway, which is linked to stemness suppression and drug sensitivity increase of HCC cells [109]. The gene discussed is SENP2; the disease is hepatocellular carcinoma.